These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

552 related items for PubMed ID: 26216407

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The inhibitory effect of ginsan on TGF-β mediated fibrotic process.
    Ahn JY, Kim MH, Lim MJ, Park S, Lee SL, Yun YS, Song JY.
    J Cell Physiol; 2011 May; 226(5):1241-7. PubMed ID: 20945375
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Inhibition of lncRNA PFRL prevents pulmonary fibrosis by disrupting the miR-26a/smad2 loop.
    Jiang H, Chen Y, Yu T, Zhao X, Shan H, Sun J, Zhang L, Li X, Shan H, Liang H.
    Am J Physiol Lung Cell Mol Physiol; 2018 Oct 01; 315(4):L563-L575. PubMed ID: 29952219
    [Abstract] [Full Text] [Related]

  • 7. Glycosyltransferases and glycosaminoglycans in bleomycin and transforming growth factor-β1-induced pulmonary fibrosis.
    Venkatesan N, Tsuchiya K, Kolb M, Farkas L, Bourhim M, Ouzzine M, Ludwig MS.
    Am J Respir Cell Mol Biol; 2014 Mar 01; 50(3):583-94. PubMed ID: 24127863
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. miR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosis.
    Liu G, Friggeri A, Yang Y, Milosevic J, Ding Q, Thannickal VJ, Kaminski N, Abraham E.
    J Exp Med; 2010 Aug 02; 207(8):1589-97. PubMed ID: 20643828
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. miR-18a-5p Inhibits Sub-pleural Pulmonary Fibrosis by Targeting TGF-β Receptor II.
    Zhang Q, Ye H, Xiang F, Song LJ, Zhou LL, Cai PC, Zhang JC, Yu F, Shi HZ, Su Y, Xin JB, Ma WL.
    Mol Ther; 2017 Mar 01; 25(3):728-738. PubMed ID: 28131417
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. lncRNA PFAL promotes lung fibrosis through CTGF by competitively binding miR-18a.
    Li X, Yu T, Shan H, Jiang H, Sun J, Zhao X, Su W, Yang L, Shan H, Liang H.
    FASEB J; 2018 Oct 01; 32(10):5285-5297. PubMed ID: 29683732
    [Abstract] [Full Text] [Related]

  • 16. Latent transforming growth factor-beta-binding protein-4 regulates transforming growth factor-beta1 bioavailability for activation by fibrogenic lung fibroblasts in response to bleomycin.
    Zhou Y, Koli K, Hagood JS, Miao M, Mavalli M, Rifkin DB, Murphy-Ullrich JE.
    Am J Pathol; 2009 Jan 01; 174(1):21-33. PubMed ID: 19056849
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. MicroRNA-101 attenuates pulmonary fibrosis by inhibiting fibroblast proliferation and activation.
    Huang C, Xiao X, Yang Y, Mishra A, Liang Y, Zeng X, Yang X, Xu D, Blackburn MR, Henke CA, Liu L.
    J Biol Chem; 2017 Oct 06; 292(40):16420-16439. PubMed ID: 28726637
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Sphingosine kinase 1 regulates differentiation of human and mouse lung fibroblasts mediated by TGF-beta1.
    Kono Y, Nishiuma T, Nishimura Y, Kotani Y, Okada T, Nakamura S, Yokoyama M.
    Am J Respir Cell Mol Biol; 2007 Oct 06; 37(4):395-404. PubMed ID: 17641298
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.